Hormone replacement therapy and Parkinson’s disease risk in women: a meta-analysis of 14 observational studies

Código QR

Hormone replacement therapy and Parkinson’s disease risk in women: a meta-analysis of 14 observational studies

Peifu Wang, Jilai Li, Shi Qiu, Honfeng Wen, Jichen DuDepartment of Neurology, Aerospace Center Hospital, Peking University Aerospace Clinical College, Beijing, People’s Republic of ChinaBackground and purpose: Published data on the relationship of hormone replacement therapy (HRT) with Pa...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wang P, Li J, Qiu S, Wen H, Du J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/5bd63efc854145f5822a97fbec8d04ea
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Systematic review of the prevalence and incidence of Parkinson’s disease in the People’s Republic of China
por: Zou YM, et al.
Publicado: (2015)

Pathways to Parkinson’s disease: a spotlight on 14-3-3 proteins
por: E. Giusto, et al.
Publicado: (2021)

Rasagiline in treatment of Parkinson&rsquo;s disease
por: Lakshmi Nayak, et al.
Publicado: (2008)

Parkinson’s disease-associated melanin steal
por: Hinz M, et al.
Publicado: (2014)

Sleep disorders in Parkinson&rsquo;s disease
por: Israt Jahan, et al.
Publicado: (2009)

Ceruloplasmin and iron in Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease: a synopsis of recent studies
por: Kristinsson J, et al.
Publicado: (2012)

Optimizing levodopa therapy for Parkinson&rsquo;s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective
por: David J Brooks
Publicado: (2008)

Prevalence of Parkinson’s disease and other types of Parkinsonism in Al Kharga district, Egypt
por: El-Tallawy HN, et al.
Publicado: (2013)

Current approaches to the treatment of Parkinson&rsquo;s disease
por: Joseph Jankovic, et al.
Publicado: (2008)

Update on ropinirole in the treatment of Parkinson&rsquo;s disease
por: Holly A Shill, et al.
Publicado: (2008)

Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis
por: Zhang H, et al.
Publicado: (2019)

Potential cellular and regenerative approaches for the treatment of Parkinson&rsquo;s disease
por: Emma L Lane, et al.
Publicado: (2008)

Rivastigmine for the treatment of dementia associated with Parkinson&rsquo;s disease
por: Jennifer L Reingold, et al.
Publicado: (2007)

Update on the use of pramipexole in the treatment of Parkinson&rsquo;s disease
por: Radu Constantinescu
Publicado: (2008)

Parkinson&rsquo;s disease and the frequent reasons for emergency admission
por: Ozlem Guneysel, et al.
Publicado: (2008)

Social phobia in Parkinson’s disease: Prevalence and risk factors
por: Gultekin BK, et al.
Publicado: (2014)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
por: Bargiotas P, et al.
Publicado: (2013)

Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study
por: Schettino C, et al.
Publicado: (2016)

The association between CD157/BST1 polymorphisms and the susceptibility of Parkinson’s disease: a meta-analysis
por: Li J, et al.
Publicado: (2019)

Asymmetry of Subthalamic Neuronal Firing Rate and Oscillatory Characteristics in Parkinson’s Disease [Retraction]
por: Zhao XM, et al.
Publicado: (2020)

Do physical exercise and reading reduce the risk of Parkinson’s disease? a cross-sectional study on factors associated with Parkinson’s disease in elderly Chinese veterans
por: Zou YM, et al.
Publicado: (2015)

Subthalamic and pallidal deep brain stimulation for Parkinson’s disease—meta-analysis of outcomes
por: M. Lenard Lachenmayer, et al.
Publicado: (2021)

Cholinesterase inhibitors for gait, balance, and fall in Parkinson disease: a meta-analysis
por: Jia-Hung Chen, et al.
Publicado: (2021)

Psychiatric disorders in primary focal dystonia and in Parkinson&rsquo;s disease
por: Fernando MV Dias, et al.
Publicado: (2011)

Elevated circulating magnesium levels in patients with Parkinson’s disease: a meta-analysis
por: Jin X, et al.
Publicado: (2018)

Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series
por: Meghan Humbert, et al.
Publicado: (2017)

Parkinson&rsquo;s disease patients&rsquo; subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life
por: Skogar &Ouml;, et al.
Publicado: (2012)

Parkinson’s disease patients benefit from bicycling - a systematic review and meta-analysis
por: Marianne Tiihonen, et al.
Publicado: (2021)

Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation
por: Stefano Romano, et al.
Publicado: (2021)

Neuropsychiatric symptoms in untreated Parkinson’s disease
por: Szatmari S, et al.
Publicado: (2017)

Depression in Parkinson&rsquo;s disease: Health risks, etiology, and treatment options
por: Pasquale G Frisina, et al.
Publicado: (2008)

The impact of nocturnal disturbances on daily quality of life in patients with Parkinson’s disease
por: Yu RL, et al.
Publicado: (2015)

Beneficial effect of pramipexole for motor function and depression in Parkinson&rsquo;s disease
por: Osamu Kano, et al.
Publicado: (2009)

A randomized controlled trial of quetiapine for psychosis in Parkinson&rsquo;s disease
por: Paul Shotbolt, et al.
Publicado: (2009)

Wearing-off in Parkinson’s disease: neuropsychological differences between on and off periods
por: Caillava-Santos F, et al.
Publicado: (2015)

Depressive symptoms in Parkinson&rsquo;s disease and in non-neurological medical illnesses
por: Assogna F, et al.
Publicado: (2013)

Response inhibition in Parkinson’s disease: a meta-analysis of dopaminergic medication and disease duration effects
por: Peter Manza, et al.
Publicado: (2017)

Parkinson’s Disease-Associated Melanin Steal [Retraction]
por: Hinz M, et al.
Publicado: (2021)

Did depressive symptoms affect recognition of emotional prosody in Parkinson&rsquo;s disease?
por: Adriana V&eacute;lez Feij&oacute;, et al.
Publicado: (2008)

Cognitive behavioral group therapy versus psychoeducational intervention in Parkinson’s disease
por: Berardelli I, et al.
Publicado: (2018)